Healthcare


 Debt Monitoring in Focus: Monash IVF Group (ASX:MVF) Navigates Liabilities on the ASX 200

Debt Monitoring in Focus: Monash IVF Group (ASX:MVF) Navigates Liabilities on the ASX 200

May 21, 2025 12:33 PM AEST| By Team Kalkine Media

Highlights,Monash IVF Group (ASX:MVF) shows disciplined debt handling with increasing earnings,Free cash flow trends underline the company's financial management strategy,Rising net debt warrants close attention within broader balance sheet metrics,M...

 ASX200 Biotech Watch: Mayne Pharma (ASX:MYX) Shares Sink as Cosette Flags Deal Risk

ASX200 Biotech Watch: Mayne Pharma (ASX:MYX) Shares Sink as Cosette Flags Deal Risk

May 21, 2025 11:51 AM AEST| By Team Kalkine Media

Highlights,Mayne Pharma shares dropped,nearly 30%,amid acquisition uncertainty,Cosette Pharmaceuticals raises concerns over financial and legal issues,Potential impact on ASX200 biotech sector and investor sentiment,Mayne Pharma Group (ASX:MYX) saw i...

 Cosette Flags Concerns Over Mayne Pharma Takeover Amid ASX200 Market Movements

Cosette Flags Concerns Over Mayne Pharma Takeover Amid ASX200 Market Movements

May 21, 2025 10:55 AM AEST| By Team Kalkine Media

Highlights,Cosette questions Mayne Pharma’s financial stability,FDA letter raises issues over contraceptive product marketing,Mayne Pharma defends transparency and rejects change claims,In a development stirring interest among investors tracking the,...

 Breakthrough Osteoarthritis Therapy by Paradigm Biopharmaceuticals (ASX:PAR) Sets New Benchmark on ASX 200

Breakthrough Osteoarthritis Therapy by Paradigm Biopharmaceuticals (ASX:PAR) Sets New Benchmark on ASX 200

May 21, 2025 09:30 AM AEST| By Team Kalkine Media

Highlights:,Paradigm Biopharmaceuticals (ASX:PAR) is developing Zilosul, a PPS-based drug, to address osteoarthritis,Clinical trials show extended symptom relief and improved joint function,Exclusive partnership with bene pharmaChem strengthens manuf...

 Is Sonic Healthcare (ASX:SHL) Undervalued in 2025? ASX 200 Healthcare Stock Review

Is Sonic Healthcare (ASX:SHL) Undervalued in 2025? ASX 200 Healthcare Stock Review

May 20, 2025 06:01 PM AEST| By Team Kalkine Media

Highlights,Sonic Healthcare Ltd (ASX:SHL) operates across diagnostics and pathology sectors globally,The company’s key financial indicators show mixed performance trends in recent years,Shares are currently trading below their long-term average valua...

 Visionflex Expands Telehealth Reach Through BHP Deal, Strengthening ASX300 Presence

Visionflex Expands Telehealth Reach Through BHP Deal, Strengthening ASX300 Presence

May 20, 2025 01:36 PM AEST| By Team Kalkine Media

Highlights,Visionflex secures major telehealth rollout across BHP’s remote WA sites,Project targets improved healthcare access and reduced medevac needs,Visionflex also expands aged care support through virtual nursing initiative,Visionflex Group (AS...

 Expanding SPONTAN Access: What It Means for LTR Pharma (ASX:LTP) and ASX200 Investors

Expanding SPONTAN Access: What It Means for LTR Pharma (ASX:LTP) and ASX200 Investors

May 20, 2025 11:08 AM AEST| By Team Kalkine Media

Highlights,SPONTAN®,now,available nationwide through 600+ pharmacies.,New packaging and systems support telehealth and prescription ease.,Real-time data collection paves way for future US launch.,LTR Pharma Limited (ASX:LTP) has taken a significant s...

 Regulatory Disruption Impacts HeraMED as ASX 200 Healthcare Shifts

Regulatory Disruption Impacts HeraMED as ASX 200 Healthcare Shifts

May 19, 2025 01:30 PM AEST| By Team Kalkine Media

Highlights,HeraMED (ASX:HMD) faces partnership disruption due to Medicaid policy changes in the US,Discontinuation of HeraCARE use by Broward Health not linked to clinical performance,Company shifts focus toward markets with more urgent needs and red...

 Mayne Pharma (ASX:MYX) Trading Halt Sparks Interest Amid ASX200 Index Movements

Mayne Pharma (ASX:MYX) Trading Halt Sparks Interest Amid ASX200 Index Movements

May 19, 2025 12:19 PM AEST| By Team Kalkine Media

Highlights,Mayne Pharma enters trading halt awaiting takeover announcement,Proposed Cosette Pharmaceuticals deal values Mayne Pharma at $672 million,Shares paused amid ongoing activity in ASX200 index and ASX dividend stocks,Mayne Pharma Group (ASX:M...

 CSL and Pro Medicus: What These Two S&P/ASX200 Stocks Reveal About Healthcare Potential

CSL and Pro Medicus: What These Two S&P/ASX200 Stocks Reveal About Healthcare Potential

May 19, 2025 11:51 AM AEST| By Team Kalkine Media

Highlights,CSL and Pro Medicus draw renewed attention in the S&P/ASX200,PME shares soar over 140% from 52-week lows,CSL’s dividend yield surpasses historical average,Within the ever-evolving healthcare landscape, CSL Ltd (ASX:CSL) and Pro Medicus Ltd...

 Mayne Pharma Faces Strategic Turning Point Amid Cosette Bid – What It Means for ASX200 Investors

Mayne Pharma Faces Strategic Turning Point Amid Cosette Bid – What It Means for ASX200 Investors

May 19, 2025 10:46 AM AEST| By Team Kalkine Media

Highlights,Mayne Pharma responds to a $672 million bid from Cosette Pharmaceuticals,Trading halt requested pending formal announcement,Shares recover after independent valuation review by Deloitte,Mayne Pharma (ASX:MYX) has entered a trading halt as...

 Is Trajan Group Keeping Pace with the ASX All Ordinaries?

Is Trajan Group Keeping Pace with the ASX All Ordinaries?

May 18, 2025 10:30 AM AEST| By Team Kalkine Media

Is Trajan Group Keeping Pace with the ASX All Ordinaries?

 Is Ramsay Health Care's Valuation Reflecting Its ASX Healthcare Position?

Is Ramsay Health Care's Valuation Reflecting Its ASX Healthcare Position?

May 18, 2025 10:30 AM AEST| By Team Kalkine Media

Is Ramsay Health Care's Valuation Reflecting Its ASX Healthcare Position?

 Is Trajan Group's Leadership Aligned With Shareholder Interests on the ASX?

Is Trajan Group's Leadership Aligned With Shareholder Interests on the ASX?

May 17, 2025 10:33 AM AEST| By Team Kalkine Media

Is Trajan Group's Leadership Aligned With Shareholder Interests on the ASX?

 Is Beamtree Reflecting Sector Trends on the ASX Healthcare Index?

Is Beamtree Reflecting Sector Trends on the ASX Healthcare Index?

May 17, 2025 10:32 AM AEST| By Team Kalkine Media

Is Beamtree Reflecting Sector Trends on the ASX Healthcare Index?

 Can Neuren Pharmaceuticals Align with ASX Healthcare Sector Metrics?

Can Neuren Pharmaceuticals Align with ASX Healthcare Sector Metrics?

May 17, 2025 10:32 AM AEST| By Team Kalkine Media

Can Neuren Pharmaceuticals Align with ASX Healthcare Sector Metrics?

 Is Telix Pharmaceuticals Financially Stable in the ASX Healthcare Sector?

Is Telix Pharmaceuticals Financially Stable in the ASX Healthcare Sector?

May 16, 2025 04:32 PM AEST| By Team Kalkine Media

Is Telix Pharmaceuticals Financially Stable in the ASX Healthcare Sector?

 CSL’s 2025 Dip: What the ASX200 Healthcare Giant Signals About Long-Term Value

CSL’s 2025 Dip: What the ASX200 Healthcare Giant Signals About Long-Term Value

May 16, 2025 10:59 AM AEST| By Team Kalkine Media

Highlights,CSL’s share price sees a 15.2% decline in 2025, prompting closer scrutiny,Healthcare sector shows resilience through economic cycles,CSL’s dividend yield now exceeds its 5-year average,CSL Limited (ASX:CSL), one of Australia’s most promine...

 Could Mayne Pharma’s Takeover Evaluation Shift Sentiment on ASX Healthcare Index?

Could Mayne Pharma’s Takeover Evaluation Shift Sentiment on ASX Healthcare Index?

May 15, 2025 09:57 PM AEST| By Team Kalkine Media

Could Mayne Pharma’s Takeover Evaluation Shift Sentiment on ASX Healthcare Index?

 How Is This ASX 200 (XJO) Healthcare Stock Positioned in the Global Medical Device Market?

How Is This ASX 200 (XJO) Healthcare Stock Positioned in the Global Medical Device Market?

May 15, 2025 06:10 PM AEST| By Team Kalkine Media

How Is This ASX 200 (XJO) Healthcare Stock Positioned in the Global Medical Device Market?

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.